Compare Novavax Inc (NVAX) vs Oklo Inc (OKLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Oklo Inc — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Oklo Inc trades at $46.61 (market cap $7.22B). The key difference: Oklo Inc is far larger — about 5.6× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | OKLO | |
|---|---|---|
Market Cap | $1.30B | $7.22B |
Sector | Health | Technology |
52-Week High | $11.19 | $174.14 |
52-Week Low | $6.22 | $41.11 |
Enterprise Value | $800.50M | $5.02B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →
